The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Histone Deacetylase Inhibitors
Open accessAbstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTHistone Deacetylase InhibitorsThomas A. Miller, David J. Witter, and Sandro BelvedereView Author Information Aton Pharma, Inc., 777 Old Sawmill River Road, Tarrytown, New York 10591 Cite this: J. Med. Chem. 2003, 46, 24, 5097–5116Publication Date (Web):October 28, 2003Publication History Received24 June 2003Published online28 October 2003Published inissue 1 November 2003https://doi.org/10.1021/jm0303094Copyright © 2003 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views5211Altmetric-Citations447LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (556 KB) Get e-AlertscloseSUBJECTS:Chemical structure,Inhibition,Inhibitors,Ketones,Peptides and proteins Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Self-citationA Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
In vivo destabilization of dynamic microtubules by HDAC6‐mediated deacetylation
Matsuyama, A., Shimazu, T., Sumida, Y., Saito, A., Yoshimatsu, Y., Seigneurin‐Berny, D., Osada, H., Komatsu, Y., Nishino, N., Khochbin, S., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf682 · Cited by 720
Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., & Nakanishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4592 · Cited by 694
Grozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
Histone deacetylase inhibitors as new cancer drugs
Marks, P. A., Richon, V. M., Breslow, R., & Rifkind, R. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00010 · Cited by 531
Warrell, R. P., He, L.-Z., Richon, V., Calleja, E., & Pandolfi, P. P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1621 · Cited by 502
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412
A role for histone deacetylase activity in HDAC1-mediated transcriptional repression
Hassig, C. A., Tong, J. K., Fleischer, T. C., Owa, T., Grable, P. G., Ayer, D. E., & Schreiber, S. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3519 · Cited by 365
Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide Derivatives
Suzuki, T., Ando, T., Tsuchiya, K., Fukazawa, N., Saito, A., Mariko, Y., Yamashita, T., & Nakanishi, O. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980565u · Cited by 293
Histone deacetylase inhibitors: from target to clinical trials
Kelly, W. K., O’Connor, O. A., & Marks, P. A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1695 · Cited by 253
Inhibitors of Histone Deacetylase as New Anticancer Agents
Jung, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372058 · Cited by 213
A phase I trial of Depsipeptide (FR901228) in patients with advanced cancer
Marshall, J. L., Rizvi, N., Kauh, J., Dahut, W., Figuera, M., Kang, M. H., Figg, W. D., Wainer, I., Chaissang, C., Zhaoyang Li, M., et al. (2002) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2002.01039.x · Cited by 204
Taunton, J., Collins, J. L., & Schreiber, S. L. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9615841 · Cited by 192
Isolierung und Strukturaufklärung von Chlamydocin
Closse, A., & Huguenin, R. (1974) · Helvetica Chimica Acta · doi:10.1002/hlca.19740570306 · Cited by 190
Sternson, S. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2001) · Organic Letters · doi:10.1021/ol016915f · Cited by 145
Chronic Oral Administration of CI-994: A Phase I Study
Prakash, S., Foster, B. J., Meyer, M., Wozniak, A., Heilbrun, L. K., Flaherty, L. E., Zalupski, M. M., Radulovic, L. L., Valdivieso, M., & LoRusso, P. M. (2001) · Investigational New Drugs · doi:10.1023/a:1006489328324 · Cited by 136
Shigematsu, N., Ueda, H., Takase, S., Tanaka, H., Yamamoto, K., & TADA, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.311 · Cited by 134
Jeong, M. R., Hashimoto, R., Senatorov, V. V., Fujimaki, K., Ren, M., Lee, M. S., & Chuang, D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00350-8 · Cited by 126
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)
Curtin, M. L., Garland, R. B., Heyman, H. R., Frey, R. R., Michaelides, M. R., Li, J., Pease, L. J., Glaser, K. B., Marcotte, P. A., & Davidsen, S. K. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00622-4 · Cited by 115
Remiszewski, S., Sambucetti, L. C., Atadja, P. W., Bair, K. W., Cornell, W. D., Green, M. A., Howell, K. L., Jung, M., Kwon, P. O., Trogani, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm015568c · Cited by 113
The structure of the toxin from helminthosporium carbonum
Gross, M. L., McCrery, D. A., Crow, F. W., Tomer, K. B., Pope, M. R., Ciuffetti, L. M., Knoche, H. W., Daly, J. M., & Dunkle, L. D. (1982) · Tetrahedron Letters · doi:10.1016/0040-4039(82)80135-4 · Cited by 111
Histone Deacetylase: A Target for Antiproliferative and Antiprotozoal Agents
Meinke, P. T., & Liberator, P. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373787 · Cited by 103
Richon, V. M., Zhou, X., Rifkind, R. A., & Marks, P. A. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0376 · Cited by 93
Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases
Walter, M. W., Felici, A., Galleni, M., Soto, R. P., Adlington, R. M., Baldwin, J. E., Frère, J., Gololobov, M. Y., & Schofield, C. J. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00453-2 · Cited by 91
Structure of HC-toxin, a cyclic tetrapeptide from helminthosporium carbonum
Liesch, J. M., Sweeley, C. C., Staffeld, G. D., Anderson, M. S., Weber, D. J., & Scheffer, R. P. (1982) · Tetrahedron · doi:10.1016/0040-4020(82)85043-6 · Cited by 86
Studies on WF-3161, a new antitumor antibiotic.
UMEHARA, K., Nakahara, K., KIYOTO, S., Iwami, M., Okamoto, M., Tanaka, H., KOHSAKA, M., AOKI, H., & Imanaka, H. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.478 · Cited by 85
Rephaeli, A., Zhuk, R. A., & Nudelman, A. (2000) · Drug Development Research · Cited by 77
Massa, S., Mai, A., Sbardella, G., Esposito, M., Ragno, R., Loidl, P., & Brosch, G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015515v · Cited by 73
Bouchain, G., Leit, S. M., Fréchette, S., Khalil, E. A., Lavoie, R., Moradei, O. M., Woo, S. H., Fournel, M., Yan, P. T., Kalita, A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020377a · Cited by 72
Wittich, S., Scherf, H. R., Xie, C., Brosch, G., Loidl, P., Gerhäuser, C., & Jung, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208119 · Cited by 67
Design and synthesis of a novel class of histone deacetylase inhibitors
Lavoie, R., Bouchain, G., Fréchette, S., Woo, S. H., Khalil, E. A., Leit, S. M., Fournel, M., Yan, P. T., Trachy-Bourget, M.-C., Beaulieu, C., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00552-2 · Cited by 67
Kawai, M., Pottorf, R. S., & Rich, D. H. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00161a046 · Cited by 40
Uesato, S., Kitagawa, M., Nagaoka, Y., Maeda, T., Kuwajima, H., & Yamori, T. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00175-0 · Cited by 39
Ciuffetti, L. M., Pope, M. R., Dunkle, L. D., Daly, J. M., & Knoche, H. W. (1983) · Biochemistry · doi:10.1021/bi00283a031 · Cited by 38
Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition
Ommeslaeghe, K. V., Elaut, G., Brecx, V., Papeleu, P., Iterbeke, K., Geerlings, P., Tourwé, D., & Rogiers, V. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00284-1 · Cited by 27
Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogs of trichostatin A
Massa, S., Artico, M., Corelli, F., Mai, A., Santo, R. D., Cortes, S., Marongiu, M. E., Pani, A., & Colla, P. L. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00172a026 · Cited by 24
Seelig, M. H., & Berger, M. R. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00217-1 · Cited by 22
Development of Cytodifferentiating Agents for Cancer Chemotherapy
Breslow, R., Belvedere, S., & Gershell, L. J. (2000) · Helvetica Chimica Acta · Cited by 21
Self-citationOhtani, M., Matsuura, T., Shirahase, K., & Sugita, K. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960174k · Cited by 10
Cited by
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Ho, T. C. S., Chan, A. H. Y., & Ganesan, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00830 · Cited by 795
Acetylation of non-histone proteins modulates cellular signalling at multiple levels
Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.027 · Cited by 664
O'Connor, O. A., Horwitz, S., Masszi, T., Van Hoof, A., Brown, P., Doorduijn, J., Hess, G., Jurczak, W., Knoblauch, P., Chawla, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.2782 · Cited by 555
Metadata
- Authors
- Miller, T. A., Witter, D. J., & Belvedere, S.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-10-28
- Volume
- 46
- Issue
- 24
- Pages
- 5097-5116
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W4255691026
- Cited by
- 530
- References
- 47
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.